Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
5.92
-0.06 (-1.00%)
At close: Dec 1, 2025, 4:00 PM EST
5.97
+0.05 (0.84%)
After-hours: Dec 1, 2025, 7:11 PM EST
Neogen Market Cap
Neogen has a market cap or net worth of $1.29 billion as of December 1, 2025. Its market cap has decreased by -60.89% in one year.
Market Cap
1.29B
Enterprise Value
1.94B
1-Year Change
-60.89%
Ranking
Category
Stock Price
$5.92
Market Cap Chart
Since December 1, 1998, Neogen's market cap has increased from $43.50M to $1.29B, an increase of 2,857.26%. That is a compound annual growth rate of 13.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.29B | -51.10% |
| Dec 31, 2024 | 2.63B | -39.52% |
| Dec 29, 2023 | 4.35B | 164.86% |
| Dec 30, 2022 | 1.64B | -66.44% |
| Dec 31, 2021 | 4.89B | 15.90% |
| Dec 31, 2020 | 4.22B | 22.74% |
| Dec 31, 2019 | 3.44B | 15.87% |
| Dec 31, 2018 | 2.97B | -5.55% |
| Dec 29, 2017 | 3.14B | 25.42% |
| Dec 30, 2016 | 2.51B | 18.64% |
| Dec 31, 2015 | 2.11B | 15.26% |
| Dec 31, 2014 | 1.83B | 10.30% |
| Dec 31, 2013 | 1.66B | 53.65% |
| Dec 31, 2012 | 1.08B | 50.01% |
| Dec 30, 2011 | 720.90M | -22.72% |
| Dec 31, 2010 | 932.80M | 77.47% |
| Dec 31, 2009 | 525.60M | 44.32% |
| Dec 31, 2008 | 364.20M | -3.50% |
| Dec 31, 2007 | 377.40M | 84.73% |
| Dec 29, 2006 | 204.30M | 18.37% |
| Dec 30, 2005 | 172.60M | -5.84% |
| Dec 31, 2004 | 183.30M | 17.80% |
| Dec 31, 2003 | 155.60M | 70.05% |
| Dec 31, 2002 | 91.50M | -14.49% |
| Dec 31, 2001 | 107.00M | 131.60% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |